Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2000 | 06-2000 | 04-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 211 | -4,032 | 91 | -1,972 | -9,200 |
| Depreciation Amortization | 353 | 194 | 158 | 92 | 320 |
| Accounts receivable | N/A | -13 | N/A | -19 | -18 |
| Accounts payable and accrued liabilities | N/A | 13 | N/A | -45 | 289 |
| Other Working Capital | 294 | -967 | 233 | -808 | 240 |
| Other Operating Activity | 188 | 350 | 10 | 221 | 1,379 |
| Operating Cash Flow | $1,046 | $-4,455 | $492 | $-2,531 | $-6,990 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -2,237 | N/A | -2,236 | -2,153 |
| PPE Investments | -126 | -119 | -42 | -62 | -250 |
| Purchase Of Investment | N/A | -411 | N/A | N/A | -375 |
| Sale Of Investment | N/A | 2,153 | N/A | 2,153 | 1,591 |
| Purchase Sale Intangibles | N/A | -64 | N/A | -29 | -227 |
| Other Investing Activity | -105 | -98 | 0 | -99 | -223 |
| Investing Cash Flow | $-231 | $-712 | $-42 | $-244 | $-1,410 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -247 | N/A | -105 | N/A | N/A |
| Common Stock Issued | N/A | 10,239 | N/A | 9,378 | 4,840 |
| Common Stock Repurchased | -112 | -3,220 | -44 | -3,106 | -2,064 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -6 |
| Financing Cash Flow | $-359 | $7,019 | $-149 | $6,272 | $2,770 |
| Beginning Cash Position | 964 | 6,397 | 964 | 6,396 | 12,020 |
| End Cash Position | 1,420 | 8,249 | 1,265 | 9,893 | 6,390 |
| Net Cash Flow | $456 | $1,852 | $301 | $3,497 | $-5,620 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,046 | -4,455 | 492 | -2,531 | -6,990 |
| Capital Expenditure | -126 | -119 | -42 | -62 | -251 |
| Free Cash Flow | 920 | -4,574 | 450 | -2,593 | -7,241 |